Navigation Links
Pharmacyclics Announces Presentations and Published Abstracts on,Xcytrin at The 2007 American Society of Clinical Oncology Annual,Meeting

SUNNYVALE, Calif., May 23, 2007 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. announced today multiple presentations and a published abstract regarding Xcytrin(R) (motexafin gadolinium) Injection, including an oral presentation of Phase 3 SMART (Study of Neurologic Progression with Motexafin Gadolinium And Radiation Therapy) trial data. The presentations and publications are part of the proceedings at the 2007 American Society of Clinical Oncology Annual Meeting (ASCO) that will be held June 1-5, 2007, at McCormick Place in Chicago, IL.

    The presentations and published abstracts are as follows:


    Sunday, June 3, 2007

    Session: Central Nervous System Tumors

    Oral Presentation: Motexafin gadolinium (MGd) combined with whole brain

    radiation therapy prolongs time to neurologic progression in non-small

    cell lung cancer (NSCLC) patients with brain metastases: Pooled analysis

    of two randomized phase III trials. Abstract #2010: 3:00 - 3:15 p.m.


    Location: S100a

    Presenter: William Shapiro, M.D., Barrow Neurological Institute,

    Phoenix,AZ


    Session: Central Nervous System Tumors


    Poster Presentation: Identification of occult brain metastases amenable to

    stereotactic radiosurgery by motexafin gadolinium (MGd) based treatment

    planning MRI: Results of a phase II trial of MGd and whole brain

    radiotherapy (WBRT) with stereotactic radiosurgery (SRS).

    Abstract #2037: 8:00 a.m. - 12:00 p.m.;

    Discussion: 11:00 a.m. - 12:00 p.m.


    Poster Display Location: S102a; Discussion: S100a

    Presenter: Minesh P. Mehta, M.D., University of Wisconsin


    Motexafin Gadolinium Published Abstract

    Abstract #18001

    Title: A phase II trial of motexafin gadolinium (MGd) in advanced

    non-small-cell lung cancer (NSCLC) patients who had failed platinum-based

    chemotherapy: Preliminary results of Stage 1

About Xcytrin

Pharm
'"/>




Page: 1 2

Related medicine technology :

1. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
2. Pharmacyclics Announces Promising Results From Phase 2 Clinical Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung Cancer
3. Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Brutons Tyrosine Kinase Inhibitors
4. Pharmacyclics Announces Presentations on Its Novel and Selective HDAC and Brutons Tyrosine Kinase Inhibitor Compounds
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:1/6/2009)... of AHCC for maintaining a healthy immune system ,...ently published study in Nutrition and Cancer (6...iversity in Osaka, Japan has shown that AHCC (Acti...ction by increasing the number of dendritic cells ...ponsible for presenting foreign substances to othe...
(Date:1/6/2009).... 6 Sequella, Inc., a c... diseases of epidemic potential, announced today t...nt of tuberculosis (TB), was the first drug approv...ram contract to Dynport Vaccine Company LLC and Qu...e National Institute of Allergy and Infectious Dis...
(Date:1/6/2009)...January 6 , - Ear...ation Until,December 2011 , - Expansion of...y,Discovery in Ophthalmology , - Revised C...n,Sublicenses to a Third Party , ExonHit... reinforcement,of its existing drug discovery col...
(Date:1/5/2009)...., Jan. 5 Women undergoing in vitr...tion to help support early,pregnancy, but the int...ation,can be painful for patients. Formulations ...red by subcutaneous injection or vaginal supposito...tolerance. , With patient well-being a cons...
Breaking Medicine Technology:Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2SNM applauds NAS study showing need to restore federal nuclear medicine research funding 476 1SNM applauds NAS study showing need to restore federal nuclear medicine research funding 476 2SNM applauds NAS study showing need to restore federal nuclear medicine research funding 476 3Smart insulin nanostructures pass feasibility test UT study reports 1692 1Smart insulin nanostructures pass feasibility test UT study reports 1692 2New research sheds light on Hobbit 475 1New research sheds light on Hobbit 475 2Ancient mechanism for coping with stresses also gives cancer a boost 1686 1Ancient mechanism for coping with stresses also gives cancer a boost 1686 2Ancient mechanism for coping with stresses also gives cancer a boost 1686 3
(Date:1/8/2009)...olo., Jan. 8 Heska Corpo...ebcast: , , , What: Heska Corporation ... Year-End 2008 Earnings Conference Call on ...9:00 a.m. (MST], Where: www.heska.com (cl... Call link on the front page of this website)...
(Date:1/8/2009)...S, Jan. 8 A proposal by...s and Sailors Children,s Home has prompted the 125...to revamp its annual Mid-Winter conference January...its members, nearly unanimous opposition to the pr... more than $50,000 in direct and in-kind support t...
(Date:1/8/2009)...University and Baxter Healthcare Corporation will ... alliance, the two entities announced today. , U...ll fund research-collaboration projects at Northwe...oximately $1 million, and Baxter will determine sp...sis. Aligned with Baxter,s diversified business mo...
(Date:1/8/2009)...EE, Jan. 8 The physicians of North...th clinics in three northern Illinois,communities...a Health Care . , (Photo: http://www.newsc...e five internal medicine physicians serve patients...f Gurnee, Lindenhurst and Fox Lake. , "The ...
Breaking Medicine News(10 mins):Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2Health News:Baxter and Northwestern University partner to target new life sciences projects 2Health News:Northern Lake Medical to Join Aurora Health Care 2Health News:Northern Lake Medical to Join Aurora Health Care 3
... smoked or barbequed. // A study by American scie...nsumed the most grilled, barbecued or smoked red m...d risk of breast cancer. Big meat-eaters who also ...ercent increased risk of the disease, the scientis...
...neglected yet, crucial issue -dental care insuran...dren do not have access to dental care insurance...for Medicaid, with the poorest children this is of...edicaid, due to its low reimbursement rates. <...
...ing, but only few act. // The explanation, says P..., has two parts. One, human beings get stubbornly ...an species is biologically programmed to act in it... aren't very different from common rats on that po...
...adaches are more than twice as likely to also have...anxiety// than soldiers who do not have migraines,...nited States Army soldiers who were given a health...s after returning from one year of combat duty in ...
Other Medicine News:Health News:Barbeque Lovers Warned To Load On Fruits And Vegetables 2Health News:More Than a Toothache 2Health News:Why Humans Fail to Act on Climate Change 2Health News:Why Humans Fail to Act on Climate Change 3Health News:Migraines may Be a Symptom of Other Problems for Iraq Soldiers 2
...Single Head Rectangular Camera ,IS2s Single ...ole body scans and SPECT studies. Offering flexibi...ingle Rectangular Head Camera is an ideal camera f...purpose work, and also acquires excellent cardiac ...
...Arctic Circler uses the same cryoconsole and platf...in the pulmonary veins. Arctic Circler is an ablat...liative-only treatments that rely on medication.,...catheter has the ability to create curvilinear les...
...Aneurysm occlusion is the ultimate objective of ne...num coils. With Matrix Detachable Coils, occlusion...ls are intended for embolization of those intracra..., their location, or the patient's general medical...
Tungsten Carbide wire twister.
Medicine Products: